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Objectives: To evaluate feasibility, technical success, and the need for reintervention in the early perioperative period,
following the introduction of intraoperative DynaCT (DynaCT, Siemens AG, Berlin, Germany) in patients undergoing
infrarenal endovascular aneurysm repair (EVAR). DynaCT involves the generation of computed tomography (CT)-like
images from “on table” rotational angiographic acquisition.
Methods: A prospectively maintained database of 312 patients undergoing EVAR (September 2001 - February 2007) was
interrogated to determine incidence of early reintervention following satisfactory appearances of uniplanar completion
angiography (control group). Following the introduction of DynaCT (DynaCT group – 80 patients), clinical and
radiologic outcomes were prospectively evaluated (September 2007 - May 2008). Both groups underwent pre-discharge
computed tomographic angiography (CTA) and color-flow duplex scan. Comparative analysis of procedural data,
hospital-stay, mortality, and early reintervention between the two groups was undertaken.
Results: In the control group, 14 (4.5%) patients required reintervention procedures within 30 days of EVAR (10
endovascular, 7 surgical). Six patients had type 1 endoleaks and 8 presented with acute limb ischemia. Review of this
cohort suggested that the majority of complications (86%) may have been immediately identifiable with improved
intra-operative quality control. In the DynaCT group, DynaCT was feasible in 81.3% (n  65/80) of patients and
resulted in the detection of five clinically significant anomalies (6.25%, n  5/80). These technical problems were not
identified at completion angiography but were corrected after DynaCT (2 type 1 endoleaks, 1 type 3 endoleak, 1 limb
compression, and 1 graft thrombosis). Standard pre-discharge imaging did not identify any further graft-related
complications in the DynaCT group. Introduction of DynaCT resulted in a reduced need for early reintervention (0/80
vs 14/312, P  .05).
Conclusion: Most graft-related complications that mandate early reintervention following EVAR are due to remediable
technical problems which are not identified by uniplanar completion angiography alone. DynaCT is a feasible intra-
operative adjunct to completion angiography, which improves intra-operative quality control during endovascular repair
of abdominal aortic aneurysms. (J Vasc Surg 2009;49:288-95.)Endovascular repair (EVR) of abdominal aortic aneu-
rysms (AAA) is associated with a reduced risk of perioper-
ative death when compared to open aneurysmorrhaphy in
randomized controlled trials, but has been associated with a
higher incidence of surgical and endovascular reinterven-
tion.1 In randomized trials, early reintervention following
EVR of AAA was required in up to 10% of patients at 30
days.2 The most common indications for reintervention
were type I endoleaks, stent migration, and graft limb
thrombosis. These preventable technical problems that re-
quire early reintervention have significant cost implications
as well as having adverse consequences for the patient.
The requirement for early revisional procedures has
been demonstrated to be associated with an increased risk
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288of mortality (7.5%-8%)3,4 for endovascular aortic repair.
Most conditions that mandate early revision are due to
remediable technical problems that have not been identi-
fied or rectified during the primary procedure. At present,
many endovascular surgeons use uniplanar angiography to
assess the technical efficacy of the primary endovascular
repair. However, from the early revisional rates it would
appear that satisfactory uniplanar completion angiography
in isolation is insufficient to detect all graft-related anoma-
lies. The majority of early technical problems requiring
reintervention are detected by duplex scanning or cross-
sectional imaging performed in the interval between the
termination of the endovascular procedure and patient
discharge.5,6,7
Improving intra-operative quality control during endo-
vascular repair of AAAs is crucial to reduce early reinterven-
tion, improve cost effectiveness, and reduce perioperative
mortality/morbidity. Ideally, any method of quality con-
trol must be available during the endovascular procedure,
and would be able to effectively assess the position of the
endograft; determine the perfusion of visceral branches;
demonstrate the presence of endoleaks; define any prob-
lems with the iliac limbs, and suggest a revisional strategy.
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 2 Biasi et al 289The intra-operative gold standard for quality assurance
following endovascular aneurysm repair (EVAR) is yet to
be determined with some centers advocating the use of
biplanar angiography, intra-vascular ultrasound scan, wire-
less pressure transducers, or CO2 angiography to reduce
the incidence of technical failure.8-10
The present study investigates the use of on-table angio-
graphic computed tomography (DynaCT, Siemens Medical,
Berlin, Germany) as a method of quality control during en-
dovascular abdominal aneurysm repair.
METHODS
Study Design. The prospectively maintained database
was interrogated to determine the incidence of early rein-
tervention in patients undergoing endovascular aneurysm
repair of infrarenal aneurysms (control group). After this
review had been completed, an investigation into the use of
intra-operative DynaCT in a prospective cohort of 80 pa-
tients was instigated (DynaCT group). The change in assess-
ment protocol was approved by the New and Novel Proce-
dures Committee of our Institution, and involved the
performance of aDynaCT after uniplanar completion angiog-
raphy was deemed satisfactory. The endpoints of the study
were the technical success of the DynaCT examination, the
number of technical problems identified by DynaCT after
satisfactory completion of angiography, and the subsequent
number of early reinterventions in the perioperative period.
The findings of completion angiography and DynaCT were
independently assessed by an observer blinded to procedural
outcome.
Early reintervention rate in the control group. A
prospectively maintained database from 312 consecutive
patients undergoing EVR from September 2001 - Septem-
ber 2007 was interrogated to define the early reinterven-
tion rate in patients undergoing EVR with satisfactory
uniplanar completion angiography. For the purposes of the
present investigation, the patients in this cohort were
termed the control group. Early reintervention was defined
as a secondary surgical or endovascular procedure that
occurred within 30 days of the primary endovascular aneu-
rysm repair or during the primary hospital episode.
Quality assessment protocol in the control group. All
patients in the control group (prior to September 2007)
underwent a standard procedure for quality control after
deployment of the aortic endoprosthesis. Quality control
during infrarenal EVR relied upon uniplanar angiography
in the anterior/posterior (AP) projection to assess the
technical success of the endovascular repair. Prior to an-
giography, all stiff wires were removed and a pigtail catheter
was positioned above the level of the renal arteries. Intra-
arterial digital subtraction angiography (DSA) was then
performed using 20 mL of full strength contrast injected at
10 mL/second. The endograft was assessed for position,
integrity, flow through the graft, patency of the renal
arteries, presence of endoleak, and configuration of the iliac
limbs. If any technical problems were identified, these were
corrected, and completion angiography repeated. This se-quence was followed until technical success was achieved or
further revisional procedures were deemed inappropriate.
Following recovery from the procedure, patients un-
derwent duplex ultrasound scan and computerized tomog-
raphy assessment of the endovascular repair prior to dis-
charge. In most cases, this assessment took place the day
after EVR. Any technical defects were identified and re-
corded. The strategy for correction of any technical prob-
lems depended on the fitness of the patient and the magni-
tude of the problem. As a general principle, all patients with
type I or III endoleaks were considered for urgent revision
on the same admission, and patients with graft limb prob-
lems according to clinical need.
Change in quality assessment protocol (September
2007) – DynaCT. In September 2007, the intra-operative
quality control protocol for assessment of infrarenal EVR
was changed. The only change to endograft deployment
was an attempt to reduce contrast load by using, where
feasible, CO2 angiography in the initial positioning of the
endograft and demonstration of the iliac bifurcation. Qual-
ity control was performed as detailed above, with comple-
tion angiography guiding initial adjunctive procedures.
When completion angiography was deemed satisfactory by
the operating surgeon, patients underwent DynaCT as
described below.
Exclusion criteria from the protocol were as follows:
● preoperative serum creatinine greater than 180
mol/l;
● creatinine between 150 mol/l - 180 mol/l with
greater than 100 mL iodinated contrast usage during
procedure;
● total iodinated contrast load used greater than 200
mL;
● allergy to iodinated contrast;
● performance of the EVR in the operating room (with a
mobile image intensifier) as opposed to the angiogra-
phy suite.
The DynaCT was assessed in a non-blinded manner by
the operating surgeon at the procedure, in order to detect
any technical problems with the endovascular repair. An-
giograms and the DynaCT scans were subsequently re-
viewed by a vascular radiologist to determine if any techni-
cal problems were undiagnosed. Any technical problems
that required intervention were immediately corrected.
Postoperative assessment was with duplex and computed
tomography (CT) scanning as outlined above.
The quality of the DynaCT was assessed after EVR.
Multiplanar images were analyzed in a non-blinded fashion
by a single consultant vascular radiologist (R.M.). A visual
analogue score was devised to categorize the quality of the
images obtained from the DynaCT software into four
groups (excellent, good, adequate, and poor) based upon
contrast opacification, resolution of images, and presence
of movement artifact. A separate visual analog score was
used to record the degree of confidence in using DynaCT
to evaluate technical outcome of endograft deployment
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DynaCT scanning. The angiographic suite was
equipped with a ceiling-mounted C-arm angiography sys-
tem (SiemensMedical, Berlin, Germany) with active matrix
flat panel detector technology (30  40 cm) capable of
digital fluoroscopy, subtraction/non-subtraction, and ro-
tational angiography. Specialized software (DynaCT) was
used to generate CT-like images from on-table rota-
tional angiographic acquisitions with contrast resolution
of 10 Hounsfield units (HUs).
A total of 48 mL of radiographic contrast (Visipaque
320 mg I/mL or Omnipaque 300 mg I/mL, GE Health-
care, Oslo, Norway) at 8 mL/second (96 mL of 50%
diluted medium) was injected via a 4F pigtail catheter
placed at the level of the highest renal ostium. Angio-
graphic CT parameters, with respiration suspended, were a
0.8° increment, 512 matrix projection, 220° total angle,
20°/second, 20 frames/second with 248 projections. The
time interval from C-arm rotation to automatic generation
of images on the monitor was 122 seconds with an excur-
sion time of 8 seconds (4 second delay). Image postpro-
cessing with correction algorithms (ring correction, scatter
correction, and truncation correction) was carried out to
optimize image quality.
Multiplanar reconstructions were performed on a
commercially-available workstation (Voxar 3D, Barco,
Kortrijk, Belgium) with the images being presented as
maximum intensity projection (MIP) images in the axial,
sagittal, and coronal planes. Themean cumulative radiation
dose was 123 mGy (dose area product [DAP] 3574.0
microGY/m2).
Statistical analysis. Comparison between the two co-
horts was carried out using the 2 test (random ordinal
variables), the Fisher exact test (non random variables) and
the two-tailed t test (continuous variables) at the 5% level of
significance.
RESULTS
Early reinterventions in the control group. In the
control group, 14 patients with 15 technical problems
Table I. Secondary procedures in the control group (with
Peri-procedural complications No. patients (n  14)*
Type 1a endoleak 5
Type 1b endoleak 2
Iliac occlusion 2
Graft limb thrombosis 3
Femoral occlusion 1
Limb kinking-stenosis 2
No., Number.
*One patient required correction of both type 1a and 1b endoleaks.(4.5%, n 14/312) required 17 reintervention procedureswithin 30 days of initial EVR (10 endovascular and 7
surgical). The mean time interval between original surgery
and secondary intervention was 7 days. Nine of these
patients were symptomatic. Eight presented with acute
limb ischemia with 6 patients presenting with symptoms
prior to discharge (but before CT or duplex imaging). Two
patients with acute limb ischemia presented after discharge
from the hospital and within 30 days of their procedure.
Pre-discharge computed tomographic angiography (CTA)
and color flow duplex scans did not demonstrate any stent-
related anomalies which might have predicted limb isch-
emia in these 2 patients: 1 required femoral endarterectomy
and patch angioplasty for femoral artery occlusion and the
other developed a thromboembolic occlusion of the graft
limb. One further patient developed acute abdominal and
lumbar pain as a result of a type 1a endoleak detected prior
to undergoing pre-discharge imaging.
The remaining 5 asymptomatic patients all had demon-
strable type I a/b endoleaks on pre-discharge surveillance
detected by bothCTA and color flow duplex scan (Table I).
Retrospective review of all notes and imaging in this
cohort of 14 patients suggested that 86% of the technical
problems (n  12) were potentially identifiable and cor-
rectable with better intra-operative quality control (7 type
1a/b endoleaks in 6 patients and 6 limb kinking/stenosis/
native vessel stenosis). Overall, 3.8% of the entire patient
cohort had a potentially preventable early reintervention.
Feasibility of DynaCT. In the cohort of 80 consecu-
tive patients who underwent elective EVAR following the
introduction of the new protocol, DynaCT was feasible in
81.3% (n 65/80). Of the 15 patients who did not satisfy
the inclusion criteria for DynaCT, eight procedures were
preferentially performed in a surgical theatre using a mobile
C-arm image intensifier (Sirenmobile 2000-2; Siemens
Medical, Berlin, Germany). Six of these patients underwent
aortouniiliac graft (AUI) procedures requiring femoral to
femoral cross-over bypass. Two additional patients with
unsuitable femoral access vessels required fashioning of
common iliac conduits. Five patients were excluded from
the protocol because they exceeded the baseline creatinine
threshold as defined by the protocol. One patient had
days)
Secondary procedures No. procedures (n  17)
sion cuffs and balloon 2
on exp. stents 3
extensions 1
extensions and self-expand. stent 1
fem crossover 2
mbo-embolectomy 1 (failed)
xpand. stents 1 (failed)
mbo-embolectomy 3
ral endarterectomy 1
xpand. stents 2in 30
Exten
Ballo
Limb
Limb
Fem-
Thro
Self e
Thro
Femo
Self eproven iodinated contrast allergy, so this procedure was
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phy. A further patient required an urgent renal stent for an
inadvertently covered renal artery and exceeded the intra-
operative contrast load threshold as defined in the DynaCT
protocol.
The quality of DynaCT imaging was graded as either
good (n 29) or excellent (n 25) in the majority of cases
(83.1%) with a confidence 6-10 in 96.9 % of instances. In 2
patients (3.1%), the obtained qualities of images were con-
sidered poor due to a displaced catheter into the body of
the endograft not allowing scrutiny of the proximal landing
zone or renal vessels with adequate opacification. Both
necessitated further acquisitions following manipulation of
the pigtail catheter above the endograft which resulted in
adequately graded quality images.
Patient demographics, aneurysm morphology, and
stent grafts – control vs DynaCT cohorts (Table II).
Patient demographics and preoperative CT evaluation of
aneurysm morphology between the control and DynaCT
groups were similar with no statistically significant differ-
ences evident for age, gender, and aneurysm morphology
(neck diameter, length, angulation, and presence of en-
doluminal thrombus).
The modified Customized Probability Index (m-CPI)
was used as a preoperative scoring system to estimate
baseline fitness scores.11 Baseline fitness scores were better
in the DynaCT cohort compared with the control group
which reflected the exclusion of patients with impaired
renal function as per DynaCT protocol, but this difference
did not reach statistical significance (2.9 vs 4.3 P  .1;
Table II. Patients demographic and aneurysm
morphology (multislice 64-CT assessment)
Control group
(n  312)
DynaCT group
(n  80)
Age (years ) 75 (range, 46-93) 73 (range, 41-91)
Male gender (%) 89.7% 92.3%
m-CPI fitness score 4.3 2.9
Aneurysm diameter 61 mm (range,
42-115)
63 mm (range,
52-99)
Aneurysm neck
Length 20 mm (range,
4-90)
22 mm (range,
8-120)
Length 15 mm 24.1% 26.1%
Diameter 23 mm (range,
18-35)
24 mm (range,
20-34)
Diameter 30 mm 6.1% 9.2%
Angulation 60% 18.6% 20.0%
Thrombus 50% 7.7% 12.3%
Endografts
Zenith Flex — 62.5% (n  50)
Zenith TFB 38.1% (n  119) 23.8% (n  19)
Zenith AUI 6.7% (n  21) 2.5% (n  2)
Talent 41.7% (n  130) 11.2% (n  9)
Talent AUI 8.0% (n  25) —
Excluder 5.4% (n  17) —
Continuous variables are expressed as mean.
CT, Computed tomography; m-CPI, modified customised probability index;
TFB, Tri-Fab; AUI, aortouniiliac graft.t test).Commercial endografts deployed in the control group
included bifurcated Zenith (Cook Medical, Bloomington,
Ind) TFB (n  119), AUI Zenith (n  21), Talent
(Medtronic, Santa Rosa, Calif) (n 130), AUI Talent (n
25), and Excluder Gore (Flagstaff, Ariz) (n  17). In the
DynaCT cohort, deployed endografts included bifurcated
Zenith Flex (n  50), bifurcated Zenith TFB (n  19),
AUI Zenith (n  2), and Talent (n  9).
In the control group, 116 technical problems which
required adjunctive intra-operative procedures were de-
tected by uniplanar completion angiography in 88 patients.
This did not differ significantly compared with the 19 anom-
alies detected by initial completion angiography in 16 patients
in the DynaCT group (88/312, 28.2% vs 16/80 20.0%, P
.14, 2 test). All anomalies were immediately corrected to
achieve technical success as defined by Society for Vascular
Surgery (SVS) angiographic parameters alone.12
Procedural data. Total radiation exposure was in-
creased when compared with the control group (14,809 vs
13,315 DAP/microGy/m2 P  .1, t test and 513 vs 456
cumulated radiation dose (CRD) mGy P  .1, t test) but
this was not significant. The use of CO2 digital subtraction
angiography was significantly higher in the DynaCT cohort
compared with the control group (40% vs 8% P  .001, 2
test) and this contributed to a negligible net increase in
contrast use of 18 mLs after the DynaCT run (138 mL vs
120 mL) despite the net contrast load of 48 mL from the
DynaCT alone (Table III).
Intra-operative anomalies detected by DynaCT.
DynaCT detected five clinically significant anomalies
(6.25%, 5/80) not seen at completion angiography. Each
abnormality required on-table correction to ensure techni-
cal success. The technical problems included two anterior
type 1a endoleaks each treated with balloon dilatation (Fig
1), one type 3 endoleak corrected by balloon angioplasty, a
partial main graft thrombosis requiring balloon thrombo-
embolectomy (Fig 2), and an iliac limb compression requir-
Table III. Procedural data
Control group DynaCT group
Room occupancy
Minutes 140 145
Screening time 24= 42 24= 48
Radiation dose
DAP microGy/m2 13314.9 14808.9
CRD mGy 456 513
Contrast load
mL 120 138
Medium
Visipaque 320 69.2% 52.6%
CO2-DSA 8% 40%*
DAP, Dose-area product; CRD, cumulated radiation dose; Co2-DSA, car-
bon dioxide digital subtraction angiography.
All comparative values are statistically non significant unless denoted () in
table.
*P  .01 (2 test).ing a self-expandable nitinol stent (Luminex, Bard, Tempe,
angio
n fem
JOURNAL OF VASCULAR SURGERY
February 2009292 Biasi et alAriz). All adjunctive procedures were assessed with further
DynaCT and found to be satisfactory.
All completion angiograms were reviewed indepen-
dent of patient outcome. No patients with an angiogram
considered satisfactory by the operating surgeon was
subsequently found to have an abnormality that would
have necessitated a further intervention or procedure.
Similarly, all abnormalities identified by the operating
surgeon on DynaCT were identified by the reader
Fig 1. An 80-year-old man with a 65 mm infrarenal a
concentric calcified neck (40%) underwent an endovasc
(a) indicated apparent exclusion of the endoleak. Evalua
demonstrated a significant anterior type 1a endoleak. Fur
correction of this proximal leak at a second multiplanar
Fig 2. A 73-year-old woman with a 55 mm abdominal a
(CIA) aneurysm underwent endovascular aneurysm repa
angiographic suite. DynaCT multiplanar rendering in co
thrombus within the main body of the graft which had n
On-table graft-thrombectomy via the indwelling commoblinded to outcome.Comparative outcomes between control and
DynaCT groups. In the control group, the 30-day mor-
tality was 3.8% (12/312). The mortality in the patients that
required early reintervention in a secondary procedure was
higher than those in whom no early reintervention was
required (14.3% n 2/14 vs 3.3% n 10/298; P .038,
2 test).
Following introduction of the new protocol, the peri-
operative mortality in the DynaCT group was 2.5% (2/80).
inal aortic aneurysms (AAA) with a 28 mm diameter
epair (EVR) (bifurcated Zenith Flex). Final angiography
ith DynaCT, sagittal (b) and axial (c) reconstructions,
alloon dilatation of the aortic neck resulted in complete
graphic computed tomography (CT) (d, e).
aneurysms (AAA) and 35 mm right common iliac artery
AR) with an aorto-uni-iliac Zenith device (12F) in the
(b) sagittal (c) and axial (d, e) planes, showed an acute
en previously detected by completion angiography (a).
oral artery (CFA) sheaths was performed successfully.bdom
ular r
tion w
ther bortic
ir (EV
ronal
ot beMost significantly, no patients had a technical problem,
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 2 Biasi et al 293identified by the standard pre-discharge surveillance that
required reintervention within 30 days (P  .05, 2 test).
The overall median length of stay was greater in the
control group compared with patients undergoing DynaCT
(6 days vs 4 days, P .001, t test). Length of stay was higher
in those patients within the control group who had required
a secondary adjunctive procedure (12 days vs 5 days, P 
.001, t test).
Baseline serum creatinine was comparable between the
two groups and no significant rise in mean pre-discharge
serum creatinine was detected between control and DynaCT
groups (mean rise in creatinine of 14.8 mol/L vs 15.6
mol/L; P .4, t test). No patient in the DynaCT required
postoperative renal replacement therapy.
DISCUSSION
The clinical success of endovascular aortic procedures is
defined by the complete exclusion and decompression of
the aneurysm sac without intra-procedural evidence of
clinically relevant endoleaks or other graft-related compli-
cations (stent migration, kinking, stenosis or occlusion).12
Analyses of trial and registry data have indicated a 30-day
survival advantage for endovascular repair when compared
to open surgery.13,14 However, trial data have also demon-
strated that the endovascular techniques were associated
with a higher rate of early reintervention.2
Uniplanar completion angiography is one accepted mo-
dality for assessing the technical result of endograft insertion
during the primary endovascular procedure. However, due
to a significant false-negative rate, early duplex or CT
scanning is advised to confirm technical success.5 Data from
the Dutch Randomized Endovascular Aneurysm Manage-
ment (DREAM) study demonstrated an early vascular or
endograft-related complication rate of up to 16%.14 Simi-
larly, the EVAR I trial demonstrated that 1 in 10 patients
required early endovascular reintervention for procedural-
related complications.15 The risk of early reintervention
may be higher in patients with hostile aortic morphology.
Type I endoleaks have been reported in up to 11% of
procedures with unfavorable aneurysm morphology, pri-
marily neck angulations (60°) and short neck length
(10 mm).16
The present study has demonstrated that 3.8% of pa-
tients undergoing EVR for AAA required early reinterven-
tion due to technical problems that were not identified by
uniplanar completion angiography. Clearly these results
suggest that a better method of intra-operative quality
control is required to assess the technical success of EVR
and direct immediate revisional strategy. Preventing early
reintervention due to unidentified technical problems is
crucial to improve perioperative mortality and to improve
cost effectiveness. In the current study, the two type 1
endoleaks identified by DynaCT were anterior in location
and this makes the point that angiography, if used for
quality control, should probably be performed in at least
two planes.
The availability of DynaCT in the angiography suite
offers an immediate cross-sectional evaluation of the endo-vascular procedure. Despite reported concerns regarding in-
adequate image quality using angiographic CT, the high
contrast spatial resolution has been proven to be comparable
to conventional CTA.17 Previous isolated case reports have
demonstrated that the use of intra-procedural DynaCT may
be beneficial during cerebrovascular intervention, translum-
bar type II endoleak repair, neuro-endovascular procedures,
and intra-arterial chemo-embolization.18-23
Eide et al reported the use of DynaCT to evaluate aortic
aneurysms in 7 patients during elective EVR but did not
determine the clinical applications.24 In the present series
of 80 patients, the introduction of a new evaluation proto-
col following EVARdemonstrated that an additional 6.25%
(n  5/80) of patients benefited from immediate correc-
tion of DynaCT-detected endograft-related complications.
This prevented the need of any further secondary proce-
dure within 30-days and was associated with a significant
reduction in hospital stay.
The multi-planar rendering of the acquired high-contrast
resolution images allowed for a combined reconstruction of
stent-graft and soft tissue visualization.
The quality of images obtained by DynaCT was high,
with the presence or absence of endoleaks being decided
with a high degree of confidence. Confounding factors
influencing endoleak detection usingDynaCT included the
extensive presence of mural calcification and metal beam
artifact. Scrutiny of the images in the axial, sagittal, and
coronal planes, however, removed most of the diagnostic
uncertainty.
DynaCT evaluation required an additional iodinated
contrast load of 48 mL amounting to a mean contrast load
of 138mL. This contrast load was not significantly different
to that used in the control group, and was not associated
with any additional determinable effect upon renal func-
tion. The total procedural contrast usage in the present
study was below the nephrotoxic threshold of 5 mL of
contrast/kg body weight/serum creatinine (mg/dL).25
Greenberg et al have previously demonstrated that periop-
erative renal function was not compromised by procedural
iodinated contrast loads of up to 156-162 mL.26 A further
disadvantage ofDynaCT is the increased radiation dose to the
patient. In the present investigation, the use of DynaCT was
associated with an increased radiation exposure of 57 mGy,
whichwould appear to be relatively insignificant in the context
of endovascular repair and subsequent follow-up.
Reported strategies to minimize iodinated contrast
loads during EVR include gadolinium-based agents which
are expensive and hyperosmolar and may even be nephro-
toxic in the dosages required for EVAR,27 and the use of
CO2-DSA supplementation, which was the strategy em-
ployed in the current investigation. Chao et al have previ-
ously reported that CO2-DSA supplementation in EVAR
patients with renal insufficiency may permit a significant
reduction of iodinated contrast.28 This is in keeping with
the findings in this investigation, where the increased usage
of adjunctive CO2-DSA in the DynaCT cohort (40%, n 
32) superficially appeared to have reduced contrast loads by
up to 25% in the primary procedure, up to DynaCT evalu-
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ment of the contrast load so that even with the addition of
DynaCT, the latter cohort exhibited a non significant in-
crease of total iodinated load of only 18 mL.
This additional iodinated contrast volume is compara-
ble to the additional 20 mL load that would normally have
been administered to the patient should biplanar comple-
tion angiography had been performed. DynaCT, however,
provided additional higher resolution imaging and with the
possibility of multiplanar rendering. The current limita-
tions of DynaCT relate primarily to the dimensions of the
flat panel which provides a craniocaudal extent of the scan
of approximately 30 cm which may not be adequate to
visualize extensive endovascular repairs on a single rota-
tional acquisition.
There are a number of significant limitations to the
present study. The investigation was not randomized and,
therefore, any observations regarding hospital stay and mor-
tality rates may be due to increased experience rather than to
an improved quality-control protocol. The DynaCT group
was compared to a historical group where uniplanar angiog-
raphy was used as the primary method of quality control. It
might be argued that uniplanar angiography is not an effec-
tive method of assessing EVR and that biplanar angiogra-
phy should be used. The present investigation would sup-
port the assertion that uniplanar angiography is inadequate
for effective quality control but this methodology appears
to be in widespread use. DynaCT would appear to offer
some significant theoretical advantages to biplanar angiog-
raphy, with the ability of DynaCT to visualize the en-
dograft, aneurysm sac, and soft tissues in three projections
using appropriate windowing.
DynaCT is a feasible, reproducible, intra-procedural
technique, applicable to the majority of patients undergo-
ing endovascular aortic aneurysm repair, which aids the
immediate correction of graft-related anomalies and mini-
mizes the need for early secondary interventions. This
might result in improved patient outcomes and may have a
significant bearing on the necessity of CTA in the postop-
erative period.
Perhaps the most significant finding of the present
study has been to demonstrate that uniplanar angiography
alone is inadequate to assess the technical result of endo-
vascular aneurysm repair. DynaCT has demonstrated that
nearly 4% of patients had an unidentified, but correctable,
technical error not diagnosed by uniplanar angiography.
While we have adopted DynaCT as a method of quality
control in our unit, we realize that this will not be available
to all practitioners. In the absence of intra-operative cross-
sectional imaging, we would suggest that the assessment of
the technical adequacy of endovascular aneurysm repair
should encompass more than a uniplanar angiogram. Bipla-
nar angiography would identify many of the anterior en-
doleaks described in this study and further work will clarify
whether biplanar angiography gives similar information to
DynaCT.The authors would like to acknowledge the help of Dr
GrahamMunnike in quality assuring the findings of the study.
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